Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00964743 · ClinicalTrials.gov registry record · NA
Depocyt® With Sorafenib in Neoplastic Meningitis
A NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT00964743: Clinical Trial NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
NCT00964743 is a NA study that was terminated before completion, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00964743, a NA study, was terminated before completion, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the tolerability and side effects of oral sorafenib in combination with intrathecal DepoCyt.
Primary Outcome
Safety and tolerability of sorafenib with DepoCyt. Toxicities were to be reported using tables and descriptive statistics by type and grade. All patients were to be followed up until death.
Interventions
- DRUG Sorafenib
- DRUG DepoCyt
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2009-08 |
| Est. Completion | 2011-02 |
| Phase | NA |
Why NCT00964743 stopped before completion
NCT00964743 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Sorafenib is the first listed.
NCT00964743 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00964743 about?
NCT00964743 is a clinical study titled "Depocyt® With Sorafenib in Neoplastic Meningitis". The purpose of this study is to determine the tolerability and side effects of oral sorafenib in combination with intrathecal DepoCyt.
What is the current status of trial NCT00964743?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2009-08. Estimated completion is 2011-02.
What interventions are being tested in trial NCT00964743?
The interventions under investigation include: Sorafenib (DRUG), DepoCyt (DRUG).
Who is sponsoring clinical trial NCT00964743?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00964743's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia